Health Care & Life Sciences » Biotechnology | Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Jiangxi Boya Bio-Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
243
434
539
936
1,443
2,428
Cost of Goods Sold (COGS) incl. D&A
113
179
209
367
510
953
Gross Income
130
255
330
569
933
1,475
SG&A Expense
52
130
164
251
528
921
EBIT
77
123
162
318
405
554
Non Operating Income/Expense
-
-
24
1
11
10
Interest Expense
-
-
-
1
2
24
Pretax Income
98
140
200
328
437
577
Income Tax
15
21
31
51
66
87
Equity in Affiliates
-
4
4
3
6
4
Consolidated Net Income
82
115
167
278
365
485
Net Income
82
104
152
272
357
469
Net Income After Extraordinaries
82
104
152
272
357
469
Net Income Available to Common
82
104
152
272
357
469
EPS (Basic)
0.24
0.30
0.44
0.68
0.89
1.11
Basic Shares Outstanding
341
341
344
401
401
423
EPS (Diluted)
0.24
0.31
0.44
0.68
0.89
1.11
Diluted Shares Outstanding
341
341
344
401
401
423
EBITDA
96
151
195
367
457
621
Other Operating Expense
1
2
4
1
-
-
Non-Operating Interest Income
17
11
8
11
12
35
Minority Interest Expense
-
11
15
6
8
16

About Jiangxi Boya Bio-Pharmaceutical Co.

View Profile
Address
333 Huiquan Road
Fuzhou Jiangxi 344000
China
Employees -
Website http://www.china-boya.com
Updated 07/08/2019
Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.